Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23336228)

1.

[Clinicopathologic and cytogenetic features of 114 Chinese mantle cell lymphoma cases].

Li M, Wang XY, Xue XM, Liu CL, Huang X, Sun L, Gao ZF.

Zhonghua Xue Ye Xue Za Zhi. 2012 Sep;33(9):738-42. doi: 10.3760/cma.j.issn.0253-2727.2012.09.011. Chinese.

2.

Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.

Parrens M, Belaud-Rotureau MA, Fitoussi O, Carerre N, Bouabdallah K, Marit G, Dubus P, de Mascarel A, Merlio JP.

Histopathology. 2006 Mar;48(4):353-62.

PMID:
16487357
3.

Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.

Viswanatha DS, Foucar K, Berry BR, Gascoyne RD, Evans HL, Leith CP.

Mod Pathol. 2000 Jul;13(7):825-33.

4.

Mantle cell lymphoma in the ocular adnexal region.

Looi A, Gascoyne RD, Chhanabhai M, Connors JM, Rootman J, White VA.

Ophthalmology. 2005 Jan;112(1):114-9.

PMID:
15629830
5.

Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.

Vose JM.

Am J Hematol. 2013 Dec;88(12):1082-8. doi: 10.1002/ajh.23615. Review.

PMID:
24273091
6.

[Cytogenetic study of mantle cell lymphoma].

Wang DM, Fan L, Fang C, Zhu DX, Dong H, Yang H, Qiu HR, Hong M, Qiao C, Xu W, Li JY.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Jun;28(3):283-6. doi: 10.3760/cma.j.issn.1003-9406.2011.03.010. Chinese.

PMID:
21644224
7.

[Mantle cell lymphoma: clinicopathologic features and prognostic factors of 102 cases occurring in Chinese patients].

Ji H, Li GD, Li FY, Bai YQ, Chen Y, Yang MZ, Wang LJ, Tang Y, Zhang P, Xia T, Li C, Feng J, Zou ZK, Yixi JC.

Zhonghua Bing Li Xue Za Zhi. 2007 Nov;36(11):730-5. Chinese.

PMID:
18307875
8.

Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67.

Kimura Y, Sato K, Arakawa F, Karube K, Nomura Y, Shimizu K, Aoki R, Hashikawa K, Yoshida S, Kiyasu J, Takeuchi M, Nino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Kikuchi M, Ohshima K.

Cancer Sci. 2010 Mar;101(3):806-14. doi: 10.1111/j.1349-7006.2009.01433.x. Epub 2009 Nov 13.

PMID:
20002441
9.
10.

[Clinicopathologic features of mantle cell lymphoma and the significance of cyclin D1 in diagnosis].

He X, Li G, Liu W, Lin Y, Li F, Liao D.

Zhonghua Bing Li Xue Za Zhi. 2002 Aug;31(4):300-4. Chinese.

PMID:
12417084
11.

Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.

Chuang SS, Huang WT, Hsieh PP, Tseng HH, Campo E, Colomer D, Ye H, Lu CL, Chang HM, Cho CY, Huang SH, Lu YC, Wu JD.

Pathol Int. 2006 Aug;56(8):440-8.

PMID:
16872438
12.

Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.

Kimura Y, Sato K, Imamura Y, Arakawa F, Kiyasu J, Takeuchi M, Miyoshi H, Yoshida M, Niino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Ohshima K.

Cancer Sci. 2011 Sep;102(9):1734-41. doi: 10.1111/j.1349-7006.2011.01988.x. Epub 2011 Jun 23.

PMID:
21609366
13.

Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.

Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, Yamaguchi M, Tamaru J, Uike N, Hashimoto Y, Morishima Y, Suchi T, Seto M, Nakamura S.

Blood. 2000 Apr 1;95(7):2253-61.

14.

Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.

Espinet B, Salaverria I, Beà S, Ruiz-Xivillé N, Balagué O, Salido M, Costa D, Carreras J, Rodríguez-Vicente AE, Luís García J, Hernández-Rivas JM, Calasanz MJ, Siebert R, Ferrer A, Salar A, Carrió A, Polo N, García-Marco JA, Domingo A, González-Barca E, Romagosa V, Marugán I, López-Guillermo A, Millá F, Luís Mate J, Luño E, Sanzo C, Collado R, Oliver I, Monzó S, Palacín A, González T, Sant F, Salinas R, Ardanaz MT, Font L, Escoda L, Florensa L, Serrano S, Campo E, Solé F.

Genes Chromosomes Cancer. 2010 May;49(5):439-51. doi: 10.1002/gcc.20754.

PMID:
20143418
15.

A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited.

Chen D, Ketterling RP, Hanson CA, Colgan JP, Zent CS, Viswanatha DS.

Am J Surg Pathol. 2011 Jul;35(7):1080-4. doi: 10.1097/PAS.0b013e31821ddaec.

PMID:
21677543
16.

Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.

Bacher U, Kern W, Haferlach C, Alpermann T, Haferlach T, Schnittger S.

Exp Hematol. 2013 Dec;41(12):1028-37. doi: 10.1016/j.exphem.2013.09.004. Epub 2013 Sep 20.

PMID:
24060591
17.
18.

Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature.

Setoodeh R, Schwartz S, Papenhausen P, Zhang L, Sagatys EM, Moscinski LC, Shao H.

Int J Clin Exp Pathol. 2013;6(2):155-67. Epub 2013 Jan 15. Review.

19.

Blastic mantle cell lymphoma with a Burkitt translocation.

Reddy K, Ansari-Lari M, Dipasquale B.

Leuk Lymphoma. 2008 Apr;49(4):740-50. doi: 10.1080/10428190701852024.

PMID:
18398742
20.

Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma.

Kodama T, Ohshima K, Nomura K, Taniwaki M, Nakamura N, Nakamura S, Kohno S, Yamamoto J, Karube K, Yamasita Y, Shirakusa T, Kikuchi M.

Histopathology. 2005 Nov;47(5):467-78.

PMID:
16241994
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk